PubRank

U Ellwanger

Author PubWeight™ 21.11‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Awareness and early detection of cutaneous melanoma: an analysis of factors related to delay in treatment. Br J Dermatol 1999 1.79
2 Metastatic pathways and time courses in the orderly progression of cutaneous melanoma. Br J Dermatol 2002 1.71
3 Increase of melanocytic nevus counts in children during 5 years of follow-up and analysis of associated factors. Arch Dermatol 1996 1.65
4 Metastatic melanoma of unknown primary origin shows prognostic similarities to regional metastatic melanoma: recommendations for initial staging examinations. Cancer 1997 1.59
5 Prolonged survival of 2 years or longer for patients with disseminated melanoma. An analysis of related prognostic factors. Cancer 1997 1.12
6 Should adjuvant radiotherapy be recommended following resection of regional lymph node metastases of malignant melanomas? Br J Dermatol 2001 1.12
7 Extent and consequences of physician delay in the diagnosis of acral melanoma. Melanoma Res 1998 1.04
8 Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG). Br J Cancer 2001 1.02
9 Adjuvant low-dose interferon {alpha}2a with or without dacarbazine compared with surgery alone: a prospective-randomized phase III DeCOG trial in melanoma patients with regional lymph node metastasis. Ann Oncol 2008 0.99
10 Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma. J Invest Dermatol 2000 0.96
11 Prognostic impact of the type of anaesthesia used during the excision of primary cutaneous melanoma. Melanoma Res 2000 0.95
12 Digital image analysis for diagnosis of cutaneous melanoma. Development of a highly effective computer algorithm based on analysis of 837 melanocytic lesions. Br J Dermatol 2004 0.92
13 Value of the clinical history for different users of dermoscopy compared with results of digital image analysis. J Eur Acad Dermatol Venereol 2004 0.89
14 Amplification of MelanA messenger RNA in addition to tyrosinase increases sensitivity of melanoma cell detection in peripheral blood and is associated with the clinical stage and prognosis of malignant melanoma. Br J Dermatol 1999 0.89
15 Lymph node micrometastases of cutaneous melanoma: increased sensitivity of molecular diagnosis in comparison to immunohistochemistry. Int J Cancer 1998 0.85
16 Constrained next-to-minimal supersymmetric standard model. Phys Rev Lett 2008 0.80
17 Seasonal patterns in the diagnosis of cutaneous malignant melanoma: analysis of the data of the German Central Malignant Melanoma Registry. Br J Dermatol 1997 0.79
18 Significance of serum protein S100 levels in screening for melanoma metastasis: does protein S100 enable early detection of melanoma recurrence? Melanoma Res 2000 0.79
19 Detection of melanoma micrometastasis in sentinel nodes by reverse transcription-polymerase chain reaction correlates with tumor thickness and is predictive of micrometastatic disease in the lymph node basin. Am J Surg Pathol 1999 0.77
20 Polymerase chain reaction in the detection of circulating tumour cells in peripheral blood of melanoma patients. Recent Results Cancer Res 2001 0.76
21 [Manifestations of the "pretherapeutic phase" of malignant melanoma of the skin in Switzerland 1996-1998]. Praxis (Bern 1994) 2001 0.75
22 [The Malignant Melanoma Central Register of the German Society of Dermatology 1983-1993. Epidemiologic developments and current therapeutic management of malignant melanoma of the skin]. Hautarzt 1995 0.75
23 [Management of primary malignant melanoma of the skin in German-speaking countries 1983-1993. A study of the Malignant Melanoma Central Register of the German Society of Dermatology]. Hautarzt 1995 0.75